Early Onset of Action and Sustained Efficacy of MRI Outcomes During Cladribine Tablets Treatment in Highly Active Relapsing Multiple Sclerosis: Results of the 2-year MAGNIFY-MS Study (P6-3.018)

Early Onset of Action and Sustained Efficacy of MRI Outcomes During Cladribine Tablets Treatment in Highly Active Relapsing Multiple Sclerosis: Results of the 2-year MAGNIFY-MS Study (P6-3.018)

Abstract only

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurology 2023-04, Vol.100 (17_supplement_2)
Hauptverfasser: De Stefano, Nicola, Achiron, Anat, Barkhof, Frederik, Chan, Andrew, Derfuss, Tobias, Hodgkinson, Suzanne, Leocani, Letizia, Montalban, Xavier, Prat, Alexandre, Schmierer, Klaus, Sellebjerg, Finn, Vermersch, Patrick, Wiendl, Heinz, Keller, Birgit, Smyk, Andrzej, Gardner, Lidia
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract only
ISSN:0028-3878
1526-632X
DOI:10.1212/WNL.0000000000202977